Skip to main content
Erschienen in: The journal of nutrition, health & aging 5/2016

10.10.2015

A high-sugar high-fat diet induced metabolic syndrome shows some symptoms of Alzheimer’s disease in rats

verfasst von: L. Niu, D. W. Han, R. L. Xu, B. Han, X. Zhou, H. W. Wu, S. H. Li, C. X. Qu, M. Liu

Erschienen in: The journal of nutrition, health & aging | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Cases of sporadic Alzheimer’s disease (SAD) are the predominant form of the age-related dementia. New evidence suggests that metabolic syndrome (MS), a metabolic disorder, is an initiating factor of some SAD cases. A high-sugar high-fat diet could cause MS, we aimed to investigate whether it could directly lead to SAD.

Measurements

The characteristic molecules of AD (hippocampus Aβ and Tau) were tested by using ELISA and western blotting to confirm the happening hallmarks of AD in brain. MS and inflammation related biochemical indicators were measured using immunological method. Proteins associated with the insulin resistance signal pathway (JNK, PI-3K, AKT, GSK-3β, GLUT3) were evaluated using western blotting method. The levels of reactive oxygen species (ROS) were measured by immunofluorescence method.

Results

Expressions of hippocampus Aβ, phosphorylation-Tau (p-Tau), inflammatory factors and p-JNK, Gsk-3βwere higher in the model rats than those in the control rats and expressions of p-PI3K, p-AKT and GLUT3 were reversed.

Conclusions

The MS model animals, which can induce the characteristics symptoms of AD, and therefore it may be preliminarily considered that the AD pertains to the MS-related diseases.
Literatur
1.
Zurück zum Zitat Rasgon N, Jarvik L. Insulin resistance, affective disorders, and Alzheimer’s disease: review and hypothesis. J Gerontol A Biol Sci Med Sci 2004;59:178–83.CrossRefPubMed Rasgon N, Jarvik L. Insulin resistance, affective disorders, and Alzheimer’s disease: review and hypothesis. J Gerontol A Biol Sci Med Sci 2004;59:178–83.CrossRefPubMed
2.
Zurück zum Zitat Holscher C, Gengler S, Gault VA, Harriott P, Mallot HA. Soluble betaamyloid[ 25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning. Eur J Pharmacol 2007;561:85–90.CrossRefPubMed Holscher C, Gengler S, Gault VA, Harriott P, Mallot HA. Soluble betaamyloid[ 25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning. Eur J Pharmacol 2007;561:85–90.CrossRefPubMed
3.
Zurück zum Zitat Zetterberg H, Blennow K, Hanse E. Amyloid beta and APP as biomarkers for Alzheimer’s disease. Exp Gerontol 2010;45:23–29.CrossRefPubMed Zetterberg H, Blennow K, Hanse E. Amyloid beta and APP as biomarkers for Alzheimer’s disease. Exp Gerontol 2010;45:23–29.CrossRefPubMed
6.
Zurück zum Zitat Knight EM, Martins IV, Gümüsgöz S, Allan SM, Lawrence CB. High-fat dietinduced memory impairment in triple-transgenic Alzheimer’s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology. Neurobiol Aging 2014;35:1821–32.CrossRefPubMedPubMedCentral Knight EM, Martins IV, Gümüsgöz S, Allan SM, Lawrence CB. High-fat dietinduced memory impairment in triple-transgenic Alzheimer’s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology. Neurobiol Aging 2014;35:1821–32.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Morris MC, Tangney CC. Dietary fat composition and dementia risk. Neurobiol Aging 2014;35S2:S59–64.CrossRef Morris MC, Tangney CC. Dietary fat composition and dementia risk. Neurobiol Aging 2014;35S2:S59–64.CrossRef
8.
Zurück zum Zitat Bernard ND, Bush AI, Ceccarelli A, Cooper J, de Jager CA, Erickson KI, Fraser G, Kesler S, Levin SM, Lucey B, Morris MC, Squitti R. Dietary and lifestyle guidelines for the prevention of Alzheimer’s disease. Neurobiol Aging 2014;35S2:S74–8.CrossRef Bernard ND, Bush AI, Ceccarelli A, Cooper J, de Jager CA, Erickson KI, Fraser G, Kesler S, Levin SM, Lucey B, Morris MC, Squitti R. Dietary and lifestyle guidelines for the prevention of Alzheimer’s disease. Neurobiol Aging 2014;35S2:S74–8.CrossRef
9.
Zurück zum Zitat Vanhanen M, Koivisto K, Moilanen L,et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006;67:843–7.CrossRefPubMed Vanhanen M, Koivisto K, Moilanen L,et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006;67:843–7.CrossRefPubMed
10.
Zurück zum Zitat Craft S. Insulin resistance and Alzheimer’s disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 2007;4:147–152.CrossRefPubMed Craft S. Insulin resistance and Alzheimer’s disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 2007;4:147–152.CrossRefPubMed
11.
Zurück zum Zitat Han B, Wu F, Zhao N, et al. Study on intestinal endototemia in patients with Alzheimer’s disease. Chech Psychiafie.2012;Supp1:187. Han B, Wu F, Zhao N, et al. Study on intestinal endototemia in patients with Alzheimer’s disease. Chech Psychiafie.2012;Supp1:187.
12.
Zurück zum Zitat Talbot K, Wang H-Y, Kazi H, Han L-Y, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Investig 2012;122:1316.CrossRefPubMedPubMedCentral Talbot K, Wang H-Y, Kazi H, Han L-Y, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Investig 2012;122:1316.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Cai HY, Holscher C, Yue XH, Zhang SX, Wang XH, Qiao F, Yang W, Qi JS. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid proteininduced impairments in rats. Neuroscience 2014;2776–13. Cai HY, Holscher C, Yue XH, Zhang SX, Wang XH, Qiao F, Yang W, Qi JS. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid proteininduced impairments in rats. Neuroscience 2014;2776–13.
15.
Zurück zum Zitat DeFronzo RA. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract Suppl 2004;143:9–21.CrossRef DeFronzo RA. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract Suppl 2004;143:9–21.CrossRef
16.
Zurück zum Zitat Harte AL, da Silva NF, Creely SJ, et al. Elevated endotoxin levels in non-alcoholic fattyliver disease. Journal of Inflammation 2010;7(15):1–10. Harte AL, da Silva NF, Creely SJ, et al. Elevated endotoxin levels in non-alcoholic fattyliver disease. Journal of Inflammation 2010;7(15):1–10.
17.
Zurück zum Zitat Mehta NN, McGillicuddy FC, Anderson PD, et al. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 2010;59:172–81.CrossRefPubMedPubMedCentral Mehta NN, McGillicuddy FC, Anderson PD, et al. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 2010;59:172–81.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Wu HW, Ren LF, Zhou X, Han DW. A high-fructose diet induces hippocampal insulin resistance and exacerbates memory deficits in male Sprague-Dawley rats. Nutr Neurosci 2014. [Epub ahead of print] Wu HW, Ren LF, Zhou X, Han DW. A high-fructose diet induces hippocampal insulin resistance and exacerbates memory deficits in male Sprague-Dawley rats. Nutr Neurosci 2014. [Epub ahead of print]
19.
Zurück zum Zitat Nanes MS. Tumor necrosis factor-[alpha]: molecular and cellular mechanisms in skeletal pathology. Gene 2003;321:1–15.CrossRefPubMed Nanes MS. Tumor necrosis factor-[alpha]: molecular and cellular mechanisms in skeletal pathology. Gene 2003;321:1–15.CrossRefPubMed
20.
Zurück zum Zitat Catrina Sims-Robinson, Bhumsoo Kim, Andrew Rosko, Eva L. Feldman. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol. 2010;6(10): 551–559.CrossRefPubMedPubMedCentral Catrina Sims-Robinson, Bhumsoo Kim, Andrew Rosko, Eva L. Feldman. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol. 2010;6(10): 551–559.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Xiaobin Tan, Junfei Gu, Bingjie Zhao, Shuyuan Wang, Jiarui Yuan. Ginseng improves cognitive deficit via the RAGE/NF-kB pathway in advanced glycation end product-induced rats. Ginseng Res 2015;39:116–124.CrossRef Xiaobin Tan, Junfei Gu, Bingjie Zhao, Shuyuan Wang, Jiarui Yuan. Ginseng improves cognitive deficit via the RAGE/NF-kB pathway in advanced glycation end product-induced rats. Ginseng Res 2015;39:116–124.CrossRef
22.
Zurück zum Zitat Bo-Ryoung Choi, Woo-Hyun Cho, Jiyoung Kim, Hyong Joo Lee, ChiHye Chung et al. Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer’s disease. Experimental & Molecular Medicine 2014;46:e75.CrossRef Bo-Ryoung Choi, Woo-Hyun Cho, Jiyoung Kim, Hyong Joo Lee, ChiHye Chung et al. Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer’s disease. Experimental & Molecular Medicine 2014;46:e75.CrossRef
23.
Zurück zum Zitat Zhang YY, Fan YC, Wang M, Wang D, Li XH. Atorvastatin attenuates the production of IL-1beta, IL-6, and TNF-alpha in the hippocampus of an amyloid beta1-42-induced rat model of Alzheimer’s disease. Clin Interv Aging 2013;8:103–10.PubMedPubMedCentral Zhang YY, Fan YC, Wang M, Wang D, Li XH. Atorvastatin attenuates the production of IL-1beta, IL-6, and TNF-alpha in the hippocampus of an amyloid beta1-42-induced rat model of Alzheimer’s disease. Clin Interv Aging 2013;8:103–10.PubMedPubMedCentral
24.
Zurück zum Zitat Takeda S, Sato N, Ikimura K, et al. Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model. Neurobiol Aging 2013;3:2064–70.CrossRef Takeda S, Sato N, Ikimura K, et al. Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model. Neurobiol Aging 2013;3:2064–70.CrossRef
25.
Zurück zum Zitat Tamagno E, Parola M, Bardini P, et al. Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem 2005;92:628–36.CrossRefPubMed Tamagno E, Parola M, Bardini P, et al. Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem 2005;92:628–36.CrossRefPubMed
26.
Zurück zum Zitat Sabio G, Kennedy NJ, Cavanagh-Kyros J, et al. Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Mol Cell Biol 2010;30:106–15.CrossRefPubMedPubMedCentral Sabio G, Kennedy NJ, Cavanagh-Kyros J, et al. Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Mol Cell Biol 2010;30:106–15.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Solinas G, Vilcu C, Neels JG, et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 2007;6:386–97.CrossRefPubMed Solinas G, Vilcu C, Neels JG, et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 2007;6:386–97.CrossRefPubMed
28.
Zurück zum Zitat Ma R, Xiong N, Huang C, et al. Erythropoietin protects PC12 cells from betaamyloid( 25-35)-induced apoptosis via PI3K/Akt signaling pathway. Neuropharmocology 2009;56:1027–34.CrossRef Ma R, Xiong N, Huang C, et al. Erythropoietin protects PC12 cells from betaamyloid( 25-35)-induced apoptosis via PI3K/Akt signaling pathway. Neuropharmocology 2009;56:1027–34.CrossRef
29.
Zurück zum Zitat Winnay JN, Boucher J, Mori MA, Ueki K, Kahn CR. A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response. Nat Med 2010;16:438–45.CrossRefPubMedPubMedCentral Winnay JN, Boucher J, Mori MA, Ueki K, Kahn CR. A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response. Nat Med 2010;16:438–45.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Schulingkamp RJ, Pagano TC, Hung D, et al. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 2010;24:855–72.CrossRef Schulingkamp RJ, Pagano TC, Hung D, et al. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 2010;24:855–72.CrossRef
31.
Zurück zum Zitat Semeels L, Van Biervliet J, Craessaerts K, et al. Gamma-Secretase heterogeneity in the Aphl subunit: relevance for Alzheimer’s disease. Science 2009;324:639–42.CrossRef Semeels L, Van Biervliet J, Craessaerts K, et al. Gamma-Secretase heterogeneity in the Aphl subunit: relevance for Alzheimer’s disease. Science 2009;324:639–42.CrossRef
32.
Zurück zum Zitat Elrod JW, Molkentin JD. Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore. Circ 2013;J77:1111–22.CrossRef Elrod JW, Molkentin JD. Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore. Circ 2013;J77:1111–22.CrossRef
33.
Zurück zum Zitat Chi LY, Wang SJ, Li XG. Poly(ADP-ribose) signal in seizures-induced neuron death. Med Hypotheses 2008;71:283–5.CrossRefPubMed Chi LY, Wang SJ, Li XG. Poly(ADP-ribose) signal in seizures-induced neuron death. Med Hypotheses 2008;71:283–5.CrossRefPubMed
34.
Zurück zum Zitat Meigs JB, Larson MG, Fox CS, Keaney JF Jr, Vasan RS, Benjamin EJ. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care 2007;30:2529–35.CrossRefPubMed Meigs JB, Larson MG, Fox CS, Keaney JF Jr, Vasan RS, Benjamin EJ. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care 2007;30:2529–35.CrossRefPubMed
35.
Zurück zum Zitat Tirosh A, Potashnik R, Bashan N, et al. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1adipocytes. J Biol Chem 2009;274:10595–602.CrossRef Tirosh A, Potashnik R, Bashan N, et al. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1adipocytes. J Biol Chem 2009;274:10595–602.CrossRef
Metadaten
Titel
A high-sugar high-fat diet induced metabolic syndrome shows some symptoms of Alzheimer’s disease in rats
verfasst von
L. Niu
D. W. Han
R. L. Xu
B. Han
X. Zhou
H. W. Wu
S. H. Li
C. X. Qu
M. Liu
Publikationsdatum
10.10.2015
Verlag
Springer Paris
Erschienen in
The journal of nutrition, health & aging / Ausgabe 5/2016
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-015-0601-1

Weitere Artikel der Ausgabe 5/2016

The journal of nutrition, health & aging 5/2016 Zur Ausgabe

Letter to the Editor

Letter to the Editor

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.